VANGUARD GROUP INC - USANA HEALTH SCIENCES INC ownership

USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 192 filers reported holding USANA HEALTH SCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of USANA HEALTH SCIENCES INC
ValueSharesWeighting
Q3 2023$91,852,537
-4.7%
1,567,182
+2.5%
0.00%0.0%
Q2 2023$96,366,032
-0.7%
1,528,649
-0.9%
0.00%0.0%
Q1 2023$97,051,806
+18.9%
1,542,954
+0.5%
0.00%0.0%
Q4 2022$81,657,213
-1.6%
1,534,910
+3.7%
0.00%0.0%
Q3 2022$82,993,000
-23.4%
1,480,683
-1.1%
0.00%
-33.3%
Q2 2022$108,352,000
-9.7%
1,497,383
-0.9%
0.00%0.0%
Q1 2022$120,037,000
-20.9%
1,510,852
+0.8%
0.00%0.0%
Q4 2021$151,672,000
+7.3%
1,498,731
-2.3%
0.00%
-25.0%
Q3 2021$141,371,000
-7.5%
1,533,308
+2.8%
0.00%0.0%
Q2 2021$152,811,000
+4.7%
1,491,859
-0.2%
0.00%0.0%
Q1 2021$145,914,000
+32.6%
1,495,013
+4.7%
0.00%
+33.3%
Q4 2020$110,073,000
+7.3%
1,427,660
+2.5%
0.00%0.0%
Q3 2020$102,608,000
+2.9%
1,393,194
+2.6%
0.00%
-25.0%
Q2 2020$99,713,000
+23.9%
1,357,935
-2.5%
0.00%
+33.3%
Q1 2020$80,479,000
-23.4%
1,393,348
+4.1%
0.00%
-25.0%
Q4 2019$105,094,000
+14.8%
1,337,925
-0.0%
0.00%
+33.3%
Q3 2019$91,525,000
-19.8%
1,338,291
-6.8%
0.00%
-25.0%
Q2 2019$114,051,000
-7.1%
1,435,868
-1.9%
0.00%
-20.0%
Q1 2019$122,803,000
-22.8%
1,464,217
+8.3%
0.01%
-28.6%
Q4 2018$159,107,000
+5.9%
1,351,456
+8.5%
0.01%
+16.7%
Q3 2018$150,182,000
+15.8%
1,245,807
+10.7%
0.01%
+20.0%
Q2 2018$129,724,000
+46.1%
1,125,098
+8.9%
0.01%
+25.0%
Q1 2018$88,787,000
+15.5%
1,033,614
-0.5%
0.00%
+33.3%
Q4 2017$76,901,000
+31.2%
1,038,490
+2.2%
0.00%0.0%
Q3 2017$58,605,000
-6.7%
1,015,674
+3.7%
0.00%0.0%
Q2 2017$62,801,000
+14.2%
979,726
+2.6%
0.00%0.0%
Q1 2017$54,984,000
-2.1%
954,590
+4.0%
0.00%0.0%
Q4 2016$56,177,000
-13.6%
917,935
+95.4%
0.00%
-25.0%
Q3 2016$64,983,000
+10.3%
469,697
-11.2%
0.00%0.0%
Q2 2016$58,915,000
-25.4%
528,719
-18.7%
0.00%
-20.0%
Q1 2016$78,959,000
-3.3%
650,288
+1.7%
0.01%0.0%
Q4 2015$81,663,000
-3.1%
639,243
+1.6%
0.01%
+66.7%
Q3 2015$84,309,000
+3.8%
629,034
+5.8%
0.00%
-40.0%
Q2 2015$81,214,000
+48.5%
594,277
+20.8%
0.01%
+25.0%
Q1 2015$54,682,000
+25.5%
492,101
+15.9%
0.00%
+33.3%
Q4 2014$43,569,000
+48.2%
424,688
+6.4%
0.00%
+50.0%
Q3 2014$29,405,000
-14.8%
399,196
-9.6%
0.00%
-33.3%
Q2 2014$34,523,000
-9.1%
441,810
-12.4%
0.00%0.0%
Q1 2014$37,997,000
+1.1%
504,328
+1.4%
0.00%0.0%
Q4 2013$37,581,000
-9.5%
497,228
+4.0%
0.00%
-25.0%
Q3 2013$41,510,000
+31.8%
478,273
+9.9%
0.00%
+33.3%
Q2 2013$31,489,000435,0490.00%
Other shareholders
USANA HEALTH SCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
DENALI ADVISORS LLC 50,729$3,190,8541.33%
Cypress Capital, LLC 12,227$769,0780.25%
DGS Capital Management, LLC 6,835$429,9220.24%
PZENA INVESTMENT MANAGEMENT LLC 818,384$51,476,3540.22%
WINTON GROUP Ltd 26,950$1,695,1550.10%
Renaissance Technologies 1,211,797$76,2220.10%
Covestor Ltd 1,602$1010.09%
ACADIAN ASSET MANAGEMENT LLC 267,057$16,7780.07%
Ifrah Financial Services, Inc. 3,368$211,8470.07%
CAXTON ASSOCIATES LP 5,928$372,8710.06%
View complete list of USANA HEALTH SCIENCES INC shareholders